Weimai Qingtong Medical Technology (Wuxi) Co., Ltd. announced that it has received nears CNY 100 million in a round of funding on March 13, 2024. The transaction involved participation from new investor CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53.4 CNY | -0.32% | -3.09% | -21.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.67% | 3.1B | |
+0.32% | 262B | |
+18.76% | 20.37B | |
-.--% | 19.29B | |
+16.91% | 12.64B | |
-16.59% | 8.94B | |
+33.93% | 8.62B | |
+9.55% | 5.93B | |
-12.08% | 3.92B | |
-16.83% | 3.84B |
- Stock Market
- Equities
- 300957 Stock
- News Yunnan Botanee Bio-Technology Group Co.LTD
- Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.